NCT00619840

Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 363 (actual)
• Sponsor: Medice Arzneimittel Pütter GmbH & Co KG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Investigation of efficacy and tolerability of extended-release MPD in adults with ADHD, compared with a placebo, and to acquire knowledge through long-term observation of adults

Conditions

• Attention Deficit Hyperactivity Disorder

Interventions

Type	Name	Description
DRUG	methylphenidate hydrochloride	sustained release, 10 mg capsule 1-3 capsules twice daily according to an individual titration schedule
DRUG	Placebo	10 mg capsule 1-3 capsules twice daily according to an individual titration schedule

Timeline

• Start date: 2004-11-01
• Primary completion: 2006-05-01
• First posted: 2008-02-21
• Last updated: 2008-02-21

Locations

1 site across 1 country: Germany